Results 261 to 270 of about 148,446 (303)
Some of the next articles are maybe not open access.
2010
Pulmonary embolism is a complication of venous thrombosis. It is a major cause of morbidity and mortality, but a condition that is highly preventable and, when diagnosed, very effectively treated. Yet in the United States, more people die of pulmonary embolism each year than of AIDS. The clinician must maintain a high index of suspicion at all times in
openaire +2 more sources
Pulmonary embolism is a complication of venous thrombosis. It is a major cause of morbidity and mortality, but a condition that is highly preventable and, when diagnosed, very effectively treated. Yet in the United States, more people die of pulmonary embolism each year than of AIDS. The clinician must maintain a high index of suspicion at all times in
openaire +2 more sources
Treatment of Venous Thromboembolism
Thrombosis and Haemostasis, 1995This review provides meta-analytic data of studies aiming at improved treatment of deep vein thrombosis and pulmonary embolism. The introduction of low molecular weight heparin has considerably ameliorated the initial treatment of deep vein thrombosis, and should now be regarded as the treatment of choice for most patients with deep vein thrombosis ...
ten Cate, J. W. +3 more
openaire +3 more sources
Cancer and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006The evidence of the important two-way clinical correlation between cancer and venous thromboembolism (VTE) dates back to Trousseau's time. Over time it has been established that cancer patients not only exhibit a higher risk of developing VTE when compared with noncancer patients, but also that VTE, especially in its idiopathic presentation, sometimes ...
Piccioli A +4 more
openaire +3 more sources
Pregnancy and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2013Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been ...
Barco, Stefano +2 more
openaire +2 more sources
Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, 1998The activation of coagulation in patients with cancer contributes significantly to morbidity and mortality rates and may play a fundamental role in the host response to growing tumours. Patients with cancer are clearly at high risk for the development of venous thromboembolism (VTE), particularly during chemotherapy and surgery.
F R, Rickles, M N, Levine
openaire +2 more sources
Preventing venous thromboembolism
Nursing Management, 2005Learn to recognize who's at risk for potentially fatal complications and how to reduce your patient's risks.
openaire +3 more sources
Hyperhomocysteinemia and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006Homocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of methionine, which is dependent on vitamins (folic acid, B12 and B6) as cofactors or cosubstrates. Severe hyperhomocysteinemia (homocystinuria), due to inherited metabolic defects of Hcy metabolism, is associated with very high risk of venous thromboembolism (VTE ...
openaire +2 more sources
2020
Venous thromboembolism is a major cause of maternal mortality and morbidity. This chapter discusses thromboprophylaxis (including low-molecular-weight heparin and doses by patient weight), risk factors, deep vein thrombosis, pulmonary embolism, associated investigations, and management. Anticoagulants and bleeding while anticoagulated are both covered.
Charlotte Frise, Sally Collins
openaire +1 more source
Venous thromboembolism is a major cause of maternal mortality and morbidity. This chapter discusses thromboprophylaxis (including low-molecular-weight heparin and doses by patient weight), risk factors, deep vein thrombosis, pulmonary embolism, associated investigations, and management. Anticoagulants and bleeding while anticoagulated are both covered.
Charlotte Frise, Sally Collins
openaire +1 more source
Treatment of venous thromboembolism
International Journal of Hematology, 2000The combination of heparin and oral anticoagulants has been the treatment of choice for most patients with venous thromboembolism in the last two decades. Heparin has been proven to be effective when administered by intravenous continuous infusion or by subcutaneous injection. Oral anticoagulants should be started at the same time and heparin should be
openaire +5 more sources